Effect of EGFR amplification on survival of patients with EGFR mutation-positive non-small cell lung cancer.

被引：0
|
作者：
Xu, Yiquan [1 ]
Wang, Haibo [1 ]
Zheng, Xinlong [1 ]
Lin, Gen [1 ]
机构：
[1] Fujian Med Univ, Canc Hosp, Fujian Canc Hosp, Fuzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21000
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Nivolumab for Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Funazo, T.
    Yasuda, Y.
    Hirai, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2416 - S2416
  • [2] Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Lilenbaum, Rogerio A.
    Horn, Leora A.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (5.5): : 672 - 674
  • [3] Safety of EGFR-TKIs for EGFR mutation-positive non-small cell lung cancer
    Zhou, Jia-Ying
    Liu, Si-Yang
    Wu, Yi-Long
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 589 - 599
  • [4] Osimertinib for treating Patients with EGFR Mutation-Positive non-small cell Lung Cancer
    Meinrenken, Susanne
    [J]. PNEUMOLOGIE, 2018, 72 (04): : 246 - 246
  • [5] Osimertinib for the treatment of patients with EGFR mutation-positive non-small cell lung cancer
    Alsharedi, M.
    Bukamur, H.
    Elhamdani, A.
    [J]. DRUGS OF TODAY, 2018, 54 (06) : 369 - 379
  • [6] EGFR Tyrosine Kinase Inhibitor and Chemotherapy in EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Nishino, Kazumi
    Kimura, Madoka
    Inoue, Takako
    Uchida, Junji
    Kumagai, Toru
    Imamura, Fumio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S526 - S526
  • [7] The impact of osimertinib on function and health status for patients with EGFR mutation-positive advanced non-small cell lung cancer.
    Rudell, Katja
    Papadakis, Konstantinos
    Bodnar, Carolyn
    Hoyle, Christopher
    Ghiorghiu, Serban
    Ryden, Anna
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] The role of EGFR inhibitors as adjuvant therapy for EGFR mutation positive non-small cell lung cancer.
    Xie, Peng
    Tang, Wenjie
    Li, Xiaolin
    Sun, Xindong
    Yu, Jinming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] EGFR Mutation in Non-Small Cell Lung Cancer is Influenced by EGFR Amplification and Biomarkers
    Pollen, M.
    Waterman, J. P.
    Ding, M.
    Alvarez, A.
    Boyd, M.
    Streifel, J.
    Noroberg, M. L.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 655 - 655
  • [10] Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer
    Takeda, Masayuki
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 83 - 84
12345